Buscar resultados de ensayos clínicos
Blast Crisis - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis Condición: Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis Fecha: 2005-09-12 Intervenciones: Drug: imatinib mesylate Other Name: Gleevec/Glivec |
Completed |
Nombre del estudio: Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate Condición:
Fecha: 2005-01-13 Intervenciones: Drug: Dasatinib Tablets, Oral, 70 mg, twice daily, Until disease progression or intolerable toxicity, sw |
Terminated |
Nombre del estudio: Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia Condición:
|
Completed |
Nombre del estudio: An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Leukemia, Myeloid, Chronic Fecha: 2007-10-01 Intervenciones: Drug: Glivec®/Gleevec® Chemotherapy |
Completed |
Nombre del estudio: STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis Condición: Leukemia Fecha: 2000-11-06 Intervenciones: Drug: imatinib mesylate |
No longer available |
Nombre del estudio: Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant Condición: Chronic Myelogenous Leukemia Fecha: 2006-12-18 Intervenciones: Drug: nilotinib |
Approved for marketing |
Nombre del estudio: Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Chronic Myeloid Leukemia Fecha: 2009-05-18 Intervenciones: Drug: Nilotinib |
Completed |
Nombre del estudio: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis) Condición: Leukemia, Myeloid, Chronic Fecha: 2007-03-20 Intervenciones: Drug: panobinostat LBH589 |
Completed |
Nombre del estudio: A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Chronic Myeloid Leukemia Fecha: 2010-05-18 Intervenciones: Drug: Nilotinib |
Completed |
Nombre del estudio: Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Condición: Chronic Myeloid Leukemia Fecha: 2008-11-05 Intervenciones: Drug: Nilotinib |